nach oben

Erschienen in:

21.07.2016 | Brief Report

Re-emergence of genotype G9 during a five-and-a-half-year period in Turkish children with rotavirus diarrhea

verfasst von: Gulendam Bozdayi, Aylin Altay, Takaaki Yahiro, Sharnali Ahmed, Melda Meral, Bora Dogan, Bedia Dinc, Ayça Yeniaras, Yildiz Dallar Bilge, Kamruddin Ahmed

Erschienen in: Archives of Virology | Ausgabe 10/2016

Einloggen, um Zugang zu erhalten

Abstract

This study was done to understand the dynamics of rotavirus genotype distribution in Turkish children. Samples were collected from January 2006 through August 2011 from children at a hospital in Ankara. Rotavirus was detected in 28 % (241/889) of the samples. Genotype G9P[8] was predominant (28 %), followed by G1P[8] (16.3 %) and G2P[8] (15.9 %). G9 was absent in the samples from 2006 and 2007 and then re-emerged in 2008 and increased gradually. Phylogenetic analysis showed that Turkish G9 rotaviruses of the present study formed a sublineage with strains from Italy and Ethiopia, possibly indicating spread of a clone in these countries.

Bozkurt D, Selimoglu MA, Otlu B, Sandikkaya A (2015) Eight different viral agents in childhood acute gastroenteritis. Turk J Pediatr 57:68–73PubMed

Bakir M, Standaert B, Turel O, Bilge ZE, Postma M (2013) Estimating and comparing the clinical and economic impact of paediatric rotavirus vaccination in Turkey using a simple versus an advanced model. Vaccine 31:979–986CrossRefPubMed

WHO (2012) Estimated rotavirus deaths for children under 5 years of age: 2008, 453,000. http://www.who.int/immunization_monitoring/burden/rotavirus_estimates/en/index.html. Cited 13 Dec 2013

Matthijnssens J, Ciarlet M, McDonald SM, Attoui H, Banyai K, Brister JR et al (2011) Uniformity of rotavirus strain nomenclature proposed by the Rotavirus Classification Working Group (RCWG). Arch Virol 156:1397–1413CrossRefPubMedPubMedCentral

Fujii Y, Mitake H, Yamada D, Nagai M, Okadera K, Ito N et al (2016) Genome sequences of rotavirus A strains Ty-1 and Ty-3, isolated from Turkeys in Ireland in 1979. Genome Announc 4:e01565-15. doi:10.1128/genomeA.01565-15 CrossRefPubMedPubMedCentral

Aoki ST, Settembre EC, Trask SD, Greenberg HB, Harrison SC, Dormitzer PR (2009) Structure of rotavirus outer-layer protein VP7 bound with a neutralizing Fab. Science 324:1444–1447CrossRefPubMedPubMedCentral

Mitui MT, Chan PK, Nelson EA, Leung TF, Nishizono A, Ahmed K (2011) Co-dominance of G1 and emerging G3 rotaviruses in Hong Kong: a three-year surveillance in three major hospitals. J Clin Virol 50:325–333CrossRefPubMed

Mitui MT, Chandrasena TN, Chan PK, Rajindrajith S, Nelson EA, Leung TF et al (2012) Inaccurate identification of rotavirus genotype G9 as genotype G3 strains due to primer mismatch. Virol J 9:144CrossRefPubMedPubMedCentral

Tamura K, Peterson D, Peterson N, Stecher G, Nei M, Kumar S (2011) MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 28:2731–2739CrossRefPubMedPubMedCentral

10.

Zeller M, Heylen E, De Coster S, Van Ranst M, Matthijnssens J (2012) Full genome characterization of a porcine-like human G9P[6] rotavirus strain isolated from an infant in Belgium. Infect Genet Evol. 12:1492–1500CrossRefPubMed

11.

Ward R (2009) Mechanisms of protection against rotavirus infection and disease. Ped Infect Dis J. 28(3 Suppl):S57–S59CrossRef

12.

Heaton PM, Ciarlet M (2007) Vaccines: the pentavalent rotavirus vaccine: discovery to licensure and beyond. Clin Infect Dis 45:1618–1624CrossRefPubMed

13.

Durmaz R, Kalaycioglu AT, Acar S, Bakkaloglu Z, Karagoz A, Korukluoglu G et al (2014) Prevalence of rotavirus genotypes in children younger than 5 years of age before the introduction of a universal rotavirus vaccination program: report of rotavirus surveillance in Turkey. PLoS One 9:e113674CrossRefPubMedPubMedCentral

14.

Kiulia NM, Nyaga MM, Seheri ML, Wolfaardt M, van Zyl WB, Esona MD et al (2014) Rotavirus G and P types circulating in the eastern region of Kenya: predominance of G9 and emergence of G12 genotypes. Pediatr Infect Dis J. 33(Suppl 1):S85–S88CrossRef

15.

Seheri M, Nemarude L, Peenze I, Netshifhefhe L, Nyaga MM, Ngobeni HG et al (2014) Update of rotavirus strains circulating in Africa from 2007 through 2011. Pediatr Infect Dis J. 33(Suppl 1):S76–S84CrossRefPubMed

16.

Mullick S, Mandal P, Nayak MK, Ghosh S, De P, Rajendran K et al (2014) Hospital based surveillance and genetic characterization of rotavirus strains in children (<5 years) with acute gastroenteritis in Kolkata, India, revealed resurgence of G9 and G2 genotypes during 2011–2013. Vaccine 32(Suppl 1):A20–A28CrossRefPubMed

17.

Bozdayi G, Dogan B, Dalgic B, Bostanci I, Sari S, Battaloglu NO et al (2008) Diversity of human rotavirus G9 among children in Turkey. J Med Virol 80:733–740CrossRefPubMed

18.

Khamrin P, Peerakome S, Tonusin S, Malasao R, Okitsu S, Mizuguchi M et al (2007) Changing pattern of rotavirus G genotype distribution in Chiang Mai, Thailand from 2002 to 2004: decline of G9 and reemergence of G1 and G2. J Med Virol 79:1775–1782CrossRefPubMed

19.

Quaye O, McDonald S, Esona MD, Lyde FC, Mijatovic-Rustempasic S, Roy S et al (2013) Rotavirus G9P[4] in 3 countries in Latin America, 2009–2010. Emerg Infect Dis 19:1332–1333CrossRefPubMedPubMedCentral

20.

Afrad MH, Rahman MZ, Matthijnssens J, Das SK, Faruque AS, Azim T et al (2013) High incidence of reassortant G9P[4] rotavirus strain in Bangladesh: fully heterotypic from vaccine strains. J Clin Virol 58:755–756CrossRefPubMed

21.

Parashar U, Steele D, Neuzil K, Quadros C, Tharmaphornpilas P, Serhan F et al (2013) Progress with rotavirus vaccines: summary of the Tenth International Rotavirus Symposium. Exp Rev Vaccines 12:113–117CrossRef

22.

Justino MC, Araujo EC, van Doorn LJ, Oliveira CS, Gabbay YB, Mascarenhas JD et al (2012) Oral live attenuated human rotavirus vaccine (Rotarix) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first 2 years of life in Brazilian children. Mem Inst Oswaldo Cruz 107:846–853CrossRefPubMed

23.

Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S et al (2014) Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian children in the second year of life. Vaccine 32(Suppl 1):A110–A116CrossRefPubMed

24.

Bhandari N, Rongsen-Chandola T, Bavdekar A, John J, Antony K, Taneja S et al (2014) Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet 383:2136–2143CrossRefPubMedPubMedCentral

25.

Mullick S, Mukherjee A, Ghosh S, Pazhani GP, Sur D, Manna B et al (2014) Community based case-control study of rotavirus gastroenteritis among young children during 2008–2010 reveals vast genetic diversity and increased prevalence of G9 strains in Kolkata. PLoS One 9:e112970CrossRefPubMedPubMedCentral

Titel: Re-emergence of genotype G9 during a five-and-a-half-year period in Turkish children with rotavirus diarrhea
verfasst von: Gulendam Bozdayi
Aylin Altay
Takaaki Yahiro
Sharnali Ahmed
Melda Meral
Bora Dogan
Bedia Dinc
Ayça Yeniaras
Yildiz Dallar Bilge
Kamruddin Ahmed
Publikationsdatum: 21.07.2016
Verlag: Springer Vienna
Erschienen in: Archives of Virology / Ausgabe 10/2016
Print ISSN: 0304-8608
Elektronische ISSN: 1432-8798
DOI: https://doi.org/10.1007/s00705-016-2986-5

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

25.04.2024 | Hypotonie | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Re-emergence of genotype G9 during a five-and-a-half-year period in Turkish children with rotavirus diarrhea

Abstract

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 10/2016

Livestock rabies outbreaks in Shanxi province, China

Immunobiological properties of influenza A (H7N9) hemagglutinin and neuraminidase proteins

Detection and genetic characterization of hepatitis E virus (HEV) genotype 3 subtype c in wild boars in Italy

Double-stranded-RNA-specific adenosine deaminase 1 (ADAR1) is proposed to contribute to the adaptation of equine infectious anemia virus from horses to donkeys

Complete genotyping of unusual species A rotavirus G12P[11] and G10P[14] isolates and evidence of frequent in vivo reassortment among the rotaviruses detected in children with diarrhea in Kolkata, India, during 2014

Erratum to: Complete genome sequence of Colocasia bobone disease-associated virus, a putative cytorhabdovirus infecting taro

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

Adjuvante Immuntherapie verlängert Leben bei RCC

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

Update Innere Medizin